Penelope Przekop is a multifaceted professional blending her talents as a writer with decades of experience as a biopharmaceutical quality assurance and corporate compliance executive consultant. As the CEO of PDC Pharma Strategy, she leads a global consulting firm specializing in pharmaceutical R&D and commercial strategy.
With a career spanning preclinical research, regulatory affairs, and quality assurance, Ms. Przekop has held pivotal roles at industry giants including Hoechst-Roussel, Covance, Wyeth (acquired by Pfizer in 2009), Johnson & Johnson, and Novartis. Notably, she pioneered and led the first global pharmacovigilance quality and compliance departments at both Wyeth and Johnson & Johnson, setting new benchmarks in patient safety and regulatory excellence.
Ms. Przekop earned a Master of Science in Quality Systems from Kennesaw State University’s School of Engineering and a Bachelor of Science in Biology from Louisiana State University. She is an alumna of the prestigious Rutgers University Senior Leadership Program for Professional Women and the Smith College Customized Program for Women’s Leadership.
An accomplished author, Ms. Przekop has published influential works on quality management through McGraw-Hill and Productivity Press, in addition to four novels that showcase her storytelling expertise. Her unique combination of technical insight and creative vision continues to make a lasting impact on both the pharmaceutical industry and literary world.
